Guthrie E, Creed F, Dawson D, et al. A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome.
Br J Psychiatry.
1993;163:315-321.
Palsson OS, Turner MJ, Johnson DA. Hypnotherapy for irritable bowel syndrome: symptom improvement and autonomic nervous system effects. Poster presented at: Digestive Disease Week 2000; May 21-24, 2000; San Diego, CA.
Harvey RF, Hinton RA, Gunary RM, et al. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome.
Lancet.
1989;1:424-425.
Waxman D. The irritable bowel: a pathological or psychological syndrome?
J R Soc Med.
1988;81:718-720.
Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome.
Gastroenterology.
1991;100:450-457.
Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome—the effect of hypnotherapy.
Aliment Pharmacol Ther.
1996;10:91-95.
Rees WD, Evans BK, Rhodes J. Treating irritable bowel syndrome with peppermint oil.
Br Med J.
1979;2:835-836.
Dew MJ, Evans BK, Rhodes J. Peppermint oil for the irritable bowel syndrome: a multicentre trial.
Br J Clin Pract.
1984;38:394,398.
Lawson MJ, Knight RE, Tran K, et al. Failure of enteric-coated peppermint oil in the irritable bowel syndrome: a randomized, double-blind crossover study.
J Gastroenterol Hepatol.
1988;3:235-238.
Nash P, Gould SR, Barnardo DE. Peppermint oil does not relieve the pain of irritable bowel syndrome.
Br J Clin Pract.
1986;40:292-293.
Liu JH, Chen GH, Yeh HZ, et al. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial.
J Gastroenterol.
1997;32:765-768.
Kline RM, Kline JJ, Di Palma J, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.
J Pediatr.
2001;138:125-128.
Kline RM, Kline JJ, Di Palma J, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.
J Pediatr.
2001;138:125-128.
Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
Am J Gastroenterol.
2000;95:1231-1238.
Halpern GM, Prindiville T, Blankenburg M, et al. Treatment of irritable bowel syndrome with lacteol fort: a randomized, double-blind, cross-over trial.
Am J Gastroenterol.
1996;91:1579-1585.
Tarpila S, Kivinen A. Ground flaxseed is an effective hypolipidemic bulk laxative [abstract].
Gastroenterology.
1997;112:A836.
Smith MA, Youngs GR, Finn R. Food intolerance, atopy, and irritable bowel syndrome.
Lancet.
1985;2:1064.
McKee AM, Prior A, Whorwell PJ. Exclusion diets in irritable bowel syndrome: are they worthwhile?
J Clin Gastroenterol.
1987;9:526-528.
Jones VA, McLaughlan P, Shorthouse M, et al. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome.
Lancet.
1982;2:1115-1117.
Parker TJ, Naylor SJ, Riordan AM, et al. Management of patients with food intolerance in irritable bowel syndrome: the development and use of an exclusion diet.
J Hum Nutr Diet.
1995;8:159-166.
King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome.
Lancet.
1998;352:1187-1189.
Ballegaard M, Bjergstrom A, Brondum S, et al. Self-reported food intolerance in chronic inflammatory bowel disease.
Scand J Gastroenterol.
1997;32:569-571.
Dainese R, Galliani EA, De Lazzari F, et al. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients.
Am J Gastroenterol.
1999;94:1892-1897.
Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.
Eur J Gastroenterol Hepatol.
2001;13:1143-1147.
O’Sullivan MA, et al. Bacterial supplementaion in the irritable bowel syndrome. A randomized double-blind placebo-controlled crossover study.
Digest Liver Dis.
2000;32:294-301.
Sen S, Mullan MM, Parker TJ, et al. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.
Dig Dis Sci.
2002;47:2615-2620.
Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
Aliment Pharmacol Ther.
2003;17:895-904.
Bensoussan A, Talley NJ, Hing M, et al. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.
JAMA.
1998;280:1585-1589.
Suarez F, Levitt MD, Adshead J, et al. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal.
Dig Dis Sci.
1999;44:1317-1321.
Whorwell PJ. Use of hypnotherapy in gastrointestinal disease.
Br J Hosp Med.
1991;45:27-29.
Forbes A, Jackson S, Walter C, et al. Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial.
Gut.
2002;50:A83.
Fireman Z, Segal A, Kopelman Y, et al. Acupuncture treatment for irritable bowel syndrome. A double-blind controlled study.
Digestion.
2001;64:100-103.
Grigoleit HG, Grigoleit P. Peppermint oil in irritable bowel syndrome.
Phytomedicine.
2005;12:601-606.
Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
Neurogastroenterol Motil.
2005;17:687-696.
Niv E, Naftali T, Hallak R, et al. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome-a double blind, placebo-controlled, randomized study.
Clin Nutr.
2005 Jul 26. [Epub ahead of print]
Nickolay K. Double blind trial of metoclopramide and Iberogast® in functional gastroenterology.
Gastro Entero Hepatologie.
1984;2:4.
Song GH, Leng PH, Gwee KA, et al. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised double blind placebo controlled study.
Gut.
2005 May 24. [Epub ahead of print]
Lu WZ, Gwee KA, Moochhalla S, et al. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study.
Aliment Pharmacol Ther.
2005;22:927-934.
Brinkhaus B, Hentschel C, Von Keudell C, et al. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial.
Scand J Gastroenterol.
2005;40:936-943.
Olesen M, Gudmand-Hoyer E. Related Articles, Links
Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome.
Am J Clin Nutr.
2000;72:1570-1575.
Bittner AC, Croffut RM, Stranahan MC, et al. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Clin Ther.
2005;27:755-761.
Schneider A, Enck P, Streitberger K, et al. Acupuncture treatment in irritable bowel syndrome.
Gut.
2005 Sep 8. [Epub ahead of print]
Leung WK, Wu JC, Liang SM, et al. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Am J Gastroenterol.
2006;101:1574-1580
Vejdani R, Shalmani HR, Mir-Fattahi M, et al. The efficacy of an herbal medicine, carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study.
Dig Dis Sci.
2006 Jul 26. [Epub ahead of print]
Saha L, Malhotra S, Rana S, et al. A preliminary study of melatonin in irritable bowel syndrome.
J Clin Gastroenterol.
2007;41:29-32.
Gawronska A, Dziechciarz P, Horvath A, et al. A randomized double-blind placebo-controlled trial of
Lactobacillus GG
for abdominal pain disorders in children.
Aliment Pharmacol Ther.
2007;25:177-184.
Drisko J, Bischoff B, Hall M, et al. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics.
J Am Coll Nutr.
2006;25:514-522.
Cappello G, Spezzaferro M, Grossi L, et al. Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
Dig Liver Dis.
2007 Apr 7. [Epub ahead of print]
Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing
Bifidobacterium animalis
DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
Aliment Pharmacol Ther.
2007;26:475-486.
O’Mahony L, J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
Gastroenterology.
2005;128:541-550.
Paineau D, Payen F, Panserieu S, et al. The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders.
Br J Nutr.
2007 Aug 13. [Epub ahead of print]
Van der Veek PP, Van Rood YR, Masclee AA. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.
Aliment Pharmacol Ther.
2007;26:943-952.
Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota.
Aliment Pharmacol Ther.
2007 Oct 6. [Epub ahead of print]
Sinn DH, Song JH, Kim HJ, et al. Therapeutic effect of
Lactobacillus acidophilus
-SDC 2012, 2013 in patients with irritable bowel syndrome.
Dig Dis Sci.
2008 Feb 15.
Wilhelm SM, Brubaker CM, Varcak EA, et al. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
Pharmacotherapy.
2008;28:496-505.
Drouault-Holowacz S, Bieuvelet S, Burckel A, et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Gastroenterol Clin Biol.
2008;32:147-152.
Nikfar S, Rahimi R, Rahimi F, et al. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
Dis Colon Rectum.
2008 May 9.
McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
World J Gastroenterol.
2008;14:2650-2661.
De Paula JA, Carmuega E, Weill R. Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation.
Acta Gastroenterol Latinoam.
2008;38:16-25.
Spiller P. Review article: probiotics and prebiotics in irritable bowel syndrome (IBS).
Aliment Pharmacol Ther.
2008 Jun 4.
Williams E, Stimpson J, Wang D, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Aliment Pharmacol Ther.
2008 Sep 10.
Agrawal A, Houghton LA, Morris J, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.
Aliment Pharmacol Ther.
2008 Sep 17.
Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
BMJ.
2008 Nov 13;337:a2313.
Lembo AJ, Conboy L, Kelley JM, et al. A treatment trial of acupuncture in IBS patients.
Am J Gastroenterol.
2009;104:1489-1497.
Lahmann C, Röhricht F, Sauer N. Functional relaxation as complementary therapy in irritable bowel syndrome: a randomized, controlled clinical trial.
J Altern Complement Med.
2010;16(1):47.
Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh R. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome.
Dig Dis Sci.
2010;55(5):1385-1390.
Shinozaki M, Kanazawa M, Kano M, Endo Y, Nakaya N, Hongo M, Fukudo S.
Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial.
Appl Psychophysiol Biofeedback.
2010;35(3):189-198.
Guandalini S, Magazzù G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
J Pediatr Gastroenterol Nutr.
2010;51(1):24-30.
Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
J Clin Gastroenterol.
2011;45(8):679-683.
Gaylord SA, Palsson OS, Garland EL, et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial.
Am J Gastroenterol.
2011;106(9):1678-1688.
Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood.
Aliment Pharmacol Ther.
2011;33(12):1302-1310.
Lim B, Manheimer E, Lao L, et al. Acupuncture for treatment of irritable bowel syndrome.
Cochrane Database Syst Rev.
2006 Oct 18;(4):CD005111.
Manheimer E, Wieland LS, Cheng K, Li SM, Shen X, Berman BM, Lao L. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis.
Am J Gastroenterol.
2012 Apr 10.
Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.
Am J Gastroenterol.
2012;107(2):276-285.
Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, Tromp E, Benninga MA. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.
Gastroenterology.
2007;133(5):1430-1436.
Vlieger AM, Rutten JM, Govers AM, Frankenhuis C, Benninga MA. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome.
Am J Gastroenterol.
2012;107(4):627-631.
Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Aliment Pharmacol Ther.
2011;33(10):1123-1132.
Moser G, Trägner S, Gajowniczek EE. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
Am J Gastroenterol. 2013;108(4):602-609.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.